GSK’s $1.5b payday 

Brit pharmaco scores big with discount selloff of Haleon shares British pharmaceutical giant GSK has sold off 240 million shares in consumer health operation Haleon raising around GBP804 million (AUD$1.5 billion) for itself in the process. Haleon was created in mid-2019 as the result of a spin-off of consumer health interests from both GSK but also